News & Blog
Loss of Biological Synchrony in Skin Ageing
07/05/2025 • by The RAM Institute
Dr Dev Patel examines how disruption of inflammatory signalling, growth factor activity and circadian rhythms may contribute to visible cutaneous ageing
Abstract
Skin ageing has traditionally been attributed to cumulative cellular damage and progressive loss of regenerative capacity. Increasing biological evidence now indicates that most cutaneous cells retain functional potential throughout life, while the regulatory systems coordinating repair, renewal, and remodelling progressively deteriorate. This article proposes loss of biological synchrony – the breakdown of precise molecular timing across inflammatory, regenerative, circadian, and extracellular matrix signalling pathways – as a central driver of skin ageing. The interconnected roles of chronic inflammation, senescent cell signalling, impaired growth factor responsiveness, and circadian disruption are examined as mechanisms producing visible ageing phenotypes. Understanding ageing as regulatory failure rather than cellular exhaustion reframes regenerative aesthetics toward restoration of signalling homeostasis and tissue rhythm rather than structural replacement alone.
Clinical Significance
- Ageing reflects dysregulated biological timing rather than loss of regenerative ability
• Chronic inflammation disrupts repair sequencing
• Senescent cells distort the tissue microenvironment
• Growth factor resistance impairs coordinated regeneration
• Circadian disruption reduces nocturnal repair efficiency
Introduction
For decades, skin ageing has been interpreted primarily as a passive and inevitable decline driven by cumulative molecular damage and progressive cellular exhaustion.1 This framework assumes that fibroblasts gradually lose their capacity to synthesise collagen, keratinocyte turnover slows irreversibly, and stem cell populations diminish to the point of functional insufficiency.2 However, growing biological evidence now challenges this simplistic attrition model. Numerous studies demonstrate that most cutaneous cells remain capable of robust regenerative responses when exposed to appropriate molecular stimuli, even in advanced age. 3
Rather than intrinsic cellular failure, ageing skin increasingly appears characterised by deterioration of the regulatory networks that coordinate tissue maintenance and repair.4 In this context, ageing represents a systemic failure of biological communication rather than uniform loss of cellular potential.5 The progressive disruption of molecular timing across inflammatory, metabolic, regenerative, and circadian pathways may therefore be conceptualised as loss of biological synchrony, a regulatory collapse that underpins visible cutaneous ageing.6
Coordinated regeneration in youthful skin
Young skin functions as a dynamic regenerative organ rather than a static protective barrier.7 Following environmental injury or routine microdamage, inflammatory mediators are rapidly released to initiate immune surveillance, clear debris, and prepare tissue for repair.8 This inflammatory phase is tightly controlled and swiftly transitions into a proliferative phase driven by growth factor release, stimulating fibroblast migration, keratinocyte proliferation, angiogenesis, and extracellular matrix synthesis.9 Once repair is achieved, pro-resolution pathways actively suppress inflammation to prevent fibrosis, scarring, and chronic tissue stress.10
This regenerative cascade is orchestrated by precisely timed signalling among key growth factor families including epidermal growth factor (EGF), fibroblast growth factors (FGFs), insulin-like growth factor-1 (IGF-1), and vascular endothelial growth factor (VEGF).11 Simultaneously, extracellular matrix proteins provide not only mechanical integrity but also biochemical feedback, regulating cell migration, differentiation, and survival.12 Through these interlinked feedback loops, skin maintains continuous renewal while preserving structural stability and barrier function.13
Crucially, these regenerative processes occur rhythmically rather than continuously. Circadian signalling, mechanical forces, and metabolic cues determine when inflammation is activated, when repair is initiated, and when remodelling is completed.14 Youthful skin therefore operates through highly synchronised biological timing systems that ensure efficient regeneration with minimal collateral damage.
Regulatory breakdown in ageing skin
With advancing age, the fundamental cellular machinery responsible for regeneration remains largely preserved.15 Fibroblasts continue to synthesise collagen when appropriately stimulated, keratinocytes retain responsiveness to mitogenic cues, and stem cell populations persist despite functional attenuation.16-18 The dominant biological shift lies not in loss of these cells but in progressive dysregulation of signalling fidelity, amplitude, and temporal coordination.19
Chronic elevation of inflammatory mediators produces sustained low-grade tissue stress, a phenomenon widely described as inflammaging.20 Concurrently, growth factor receptor expression declines while downstream intracellular signalling becomes blunted, reducing cellular responsiveness to regenerative cues.21 Repair signals that once occurred in brief, tightly regulated bursts become prolonged, delayed, or insufficient to fully coordinate regeneration.22 At the same time, matrix metalloproteinases remain persistently active, tipping tissue balance toward degradation rather than renewal.23
The outcome is not regenerative failure but mistimed regeneration occurring alongside excessive breakdown, producing progressive structural deterioration despite ongoing biological activity.24
Senescence as a driver of desynchronisation
Cellular senescence plays a central role in the collapse of biological synchrony.25 Senescent fibroblasts and keratinocytes remain metabolically active yet secrete pro-inflammatory cytokines, proteases, and growth-disrupting mediators collectively termed the senescence-associated secretory phenotype (SASP).26 Rather than passively ceasing function, these cells actively distort the surrounding tissue microenvironment.27
SASP factors interfere with growth factor gradients, amplify chronic inflammation, and impair neighbouring cell responsiveness, thereby disrupting coordinated repair processes.28 This establishes a feed-forward loop in which dysregulated signalling promotes further senescence, perpetuating progressive regulatory collapse.29 Over time, accumulation of senescent cells transforms skin from a synchronised regenerative system into a chronically inflamed, poorly coordinated tissue environment.
Circadian desynchronisation and impaired repair
Skin regeneration is intimately governed by circadian biology.30 DNA repair mechanisms, epidermal proliferation, lipid barrier synthesis, and antioxidant activity peak during nocturnal phases.31 Clock genes such as BMAL1 and CLOCK regulate growth factor release, immune modulation, and cellular metabolism.32
Ageing disrupts both the amplitude and phase alignment of these circadian rhythms within cutaneous tissue.33 As a result, nocturnal repair efficiency declines, oxidative damage accumulates, and recovery from environmental stress becomes increasingly incomplete.34 Circadian desynchronisation further compounds chronic inflammation and growth factor mis-timing, accelerating visible ageing processes.35
Clinical manifestations of lost synchrony
The hallmark features of ageing skin arise directly from regulatory breakdown rather than cellular disappearance.36 Although collagen production persists, it is overwhelmed by chronic enzymatic degradation.37 Pigment signalling becomes erratic, producing uneven melanocyte activity and patchy hyperpigmentation.38 Barrier repair slows significantly, increasing transepidermal water loss and susceptibility to inflammatory insults.39
Thus, ageing skin remains biologically active yet functionally mistimed, caught in a state of perpetual low-grade injury without efficient resolution.40
Regenerative therapies as signal resynchronisation
Understanding ageing as loss of biological synchrony fundamentally reframes therapeutic strategy.41 Rather than focusing solely on replacing volume or ablating damaged tissue, modern regenerative approaches aim to restore physiological signalling cascades.42
Growth factor-based therapies reintroduce missing regenerative cues to stimulate coordinated repair.43 Energy-based devices leverage controlled microinjury to re-initiate synchronised wound-healing cycles.44 Biological modulators such as peptides and extracellular vesicle mediators influence intracellular signalling fidelity and receptor responsiveness.45
The therapeutic objective becomes restoration of proper timing between inflammation, repair, and remodelling rather than forced tissue replacement.46
Implications for longevity medicine
This regulatory model aligns closely with emerging geroscience frameworks across multiple organ systems.47 Ageing is increasingly recognised as a consequence of disrupted intercellular communication rather than irreversible cellular depletion.48 Restoration of signalling homeostasis has demonstrated tissue rejuvenation in muscle, liver, nervous tissue, and skin models.49
Skin therefore provides a visible and accessible model for studying systemic ageing biology and regenerative intervention.50
Conclusion
Skin does not age primarily because its cells lose regenerative capacity.51 Instead, ageing reflects progressive loss of precision in the molecular coordination governing repair and renewal.52 Chronic inflammation, senescent signalling, impaired growth factor responsiveness, and circadian disruption collectively drive loss of biological synchrony.53
Regenerative aesthetics should therefore focus on restoring biological rhythm and signalling integrity rather than structural replacement alone.54 The future of skin longevity lies in resynchronising regenerative systems that remain inherently capable of renewal.55

Dr Dev Patel BSc(Hons) MBBS Dip IMC RCS(Ed) DFFP Dip PgDerm MRCGP DOccMed MBCAM is an award-winning aesthetic doctor, educator, and international speaker. He holds an Honours Degree in Genetics and qualified in medicine from Guy’s, King’s & St Thomas’ in London. He also has a post-graduate diploma in dermatology from Cardiff University. He is Founder and Medical Director of the multi-award-winning Perfect Skin Solutions, and creator of CellDerma – a regenerative skincare brand focused on growth factor innovation. Widely recognised for pioneering technologies such as gas plasma and being among the first to introduce several globally acclaimed aesthetic systems to the UK, Dr Patel is also a trainer and faculty member for leading brands including Merz. His work bridges advanced science, aesthetic artistry, and the psychology of beauty.
References
- Farage MA, et al. Int J Cosmet Sci. 2008;30:87–95.
- Gilchrest BA. Dermatol Nurs. 2013;25:49–52.
- Rittié L, Fisher GJ. Cold Spring Harb Perspect Med. 2015;5:a015370.
- López-Otín C, et al. Cell. 2013;153:1194–1217.
- Campisi J. Annu Rev Physiol. 2013;75:685–705.
- Fülöp T, et al. Nat Rev Immunol. 2018;18:447–460.
- Gurtner GC, et al. Nature. 2008;453:314–321.
- Eming SA, et al. J Invest Dermatol. 2007;127:514–525.
- Barrientos S, et al. Wound Repair Regen. 2008;16:585–601.
- Serhan CN, et al. Nat Rev Immunol. 2007;7:783–796.
- Schultz GS, et al. Adv Wound Care. 2011;1:78–84.
- Hynes RO. Science. 2009;326:1216–1219.
- Elias PM. Curr Allergy Asthma Rep. 2008;8:299–305.
- Geyfman M, et al. J Invest Dermatol. 2015;135:1202–1207.
- Quan T, et al. J Investig Dermatol Symp Proc. 2009;14:20–24.
- Varani J, et al. Am J Pathol. 2006;168:1861–1868.
- Stern MM, et al. Aging Cell. 2012;11:389–396.
- Giangreco A, et al. J Invest Dermatol. 2008;128:163–169.
- Franceschi C, et al. Mech Ageing Dev. 2007;128:92–105.
- Furman D, et al. Nat Med. 2019;25:1822–1832.
- Unger J, et al. J Gerontol A. 2001;56:B478–B483.
- Shaw TJ, Martin P. J Cell Sci. 2009;122:3209–3213.
- Fisher GJ, et al. Arch Dermatol Res. 2002;294:191–197.
- López-Otín C, et al. Cell. 2023;186:243–278.
- van Deursen JM. Nature. 2014;509:439–446.
- Coppé JP, et al. Annu Rev Pathol. 2010;5:99–118.
- Childs BG, et al. Nat Rev Drug Discov. 2017;16:718–735.
- Wiley CD, et al. Cell Metab. 2016;24:87–98.
- Kirkland JL, Tchkonia T. Nat Med. 2017;23:1424–1435.
- Plikus MV, et al. Nature. 2012;490:209–214.
- Gaddameedhi S, et al. PNAS. 2011;108:18790–18795.
- Lin KK, et al. Cell. 2009;137:513–524.
- Kondratov RV. Ageing Res Rev. 2007;6:12–27.
- Kubo A, et al. J Invest Dermatol. 2010;130:2219–2228.
- Hardman MJ, et al. Aging Cell. 2015;14:874–883.
- Fisher GJ, et al. J Investig Dermatol Symp Proc. 2009;14:25–30.
- Quan T, et al. Am J Pathol. 2010;177:803–812.
- Yamaguchi Y, et al. Pigment Cell Res. 2007;20:2–13.
- Ghadially R, et al. J Clin Invest. 1995;95:2281–2290.
- Kammeyer A, Luiten RM. Int J Mol Sci. 2015;16:14418–14442.
- Blau HM, et al. Cell. 2015;161:23–34.
- Eming SA, et al. J Invest Dermatol. 2014;134:113–120.
- Schultz GS, et al. Adv Wound Care. 2011;1:78–84.
- Hantash BM, et al. Lasers Surg Med. 2007;39:381–389.
- Hu L, et al. Stem Cell Res Ther. 2020;11:1–12.
- Gurtner GC, et al. Nat Rev Mol Cell Biol. 2008;9:314–325.
- Kennedy BK, et al. Cell. 2014;159:709–713.
- da Costa JP, et al. Biogerontology. 2016;17:665–685.
- Conboy IM, et al. Nature. 2005;433:760–764.
- Makrantonaki E, et al. Exp Gerontol. 2017;94:22–27.
- Rando TA, Chang HY. Cell. 2012;148:46–57.
- López-Otín C, et al. Cell. 2016;166:802–821.
- Franceschi C, et al. Nat Rev Endocrinol. 2018;14:576–590.
- Blau HM, et al. Cell Stem Cell. 2011;8:473–485.
- Sinclair DA, LaPlante MD. Science. 2019;366:eaaw6936.








